Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) Share Price

Company Profile

Business description
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalosporins, and bone resorption inhibitors. Its products mainly focus on the areas of cardio-cerebral vascular disease, diabetes, complications, anti-tumor, and orthopedics. Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.
Contact
No. 6009, Shennan Avenue
37th Floor, Main Building, Tower B
Chegongmiao Greenview Plaza
Futian District
Shenzhen518040
CHN
T: +86 75583867888
https://www.salubris.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
4,087

Recommended

Aussie stock exchange remains materially undervalued despite growing cost concerns.

Roy Van Keulen | 29 May 2026

Questions surround Australia’s largest data center developer and its growing pipeline.

Yingqi Tan, CFA | 29 May 2026

The e-commerce business continues its sales momentum despite challenging backdrop.

Johannes Faul, CFA | 28 May 2026

Index	Last price	Change	% Change
All Ordinaries	8,965.00	77.80	0.88%
CAC 40	8,183.34	5.53	-0.07%
DAX 40	25,104.70	12.45	0.05%
Dow JONES (US)	50,986.07	317.10	0.63%
FTSE 100	10,409.28	16.68	-0.16%
HKSE	25,182.39	176.23	0.70%
NASDAQ	26,994.89	77.42	0.29%
Nikkei 225	66,329.50	1,636.38	2.53%
NZX 50 Index	13,244.55	38.44	0.29%
S&P 500	7,585.08	21.45	0.28%
S&P/ASX 200	8,731.70	73.10	0.84%
SSE Composite Index	4,068.57	30.07	-0.73%